Table 5.
Probable case |
---|
Three combinations of clinical, epidemiological, and laboratory criteria can define a probable case: |
A person with a febrile acute respiratory illness with clinical, radiological, or histopathological evidence of pulmonary parenchymal disease (e.g., pneumonia or acute respiratory distress syndrome) AND Testing for MERS-CoV is unavailable or negative on a single inadequate specimen AND The patient has a direct epidemiological link with a confirmed MERS-CoV case. |
A person with a febrile acute respiratory illness with clinical, radiological, or histopathological evidence of pulmonary parenchymal disease (e.g., pneumonia or acute respiratory distress syndrome) AND An inconclusive MERS-CoV laboratory test (i.e., a positive screening test without confirmation) AND A resident of or traveler to Middle Eastern countries where MERS-CoV virus is believed to be circulating in 14 days before onset of illness. |
A person with an acute febrile respiratory illness of any severity AND An inconclusive MERS-CoV laboratory test (i.e., a positive screening test without confirmation) AND The patient has a direct epidemiological-link with a confirmed MERS-CoV case.2 |
|
Confirmed case A person with laboratory confirmation of MERS-CoV infection. |
MERS-CoV: Middle East respiratory syndrome coronavirus, WHO: World Health Organization.